Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease

被引:5
|
作者
Banerjee, Tanima [1 ]
Mukherjee, Somaditya [1 ]
Biswas, Monodeep [2 ]
Dutta, Santanu [3 ]
Chatterjee, Shelly [1 ]
Ghosh, Sudip [1 ]
Pattari, Sanjib [4 ]
Nanda, Navin C. [5 ]
Bandyopadhyay, Arun [1 ]
机构
[1] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata 700032, India
[2] Temple Univ, Mercy Hosp, Philadelphia, PA 19122 USA
[3] SSKM Hosp, Postgrad Inst Med Educ & Res, Dept Cardiothorac & Vasc Surg, Kolkata, India
[4] Rabindra Nath Tagore Inst Cardiac Sci, Dept Pathol, Kolkata, India
[5] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
关键词
Mitral valve; Biomarker; Collagen; Fibrosis; Heart; MYOCARDIAL FIBROSIS; TURNOVER;
D O I
10.1016/j.ijcard.2012.01.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:117 / 119
页数:3
相关论文
共 50 条
  • [1] NEW INSIGHTS IN RHEUMATIC HEART DISEASE-ROLE OF CIRCULATING CARBOXY-TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN (PICP)
    Banerjee, Tanima
    Mukherjee, Somaditya
    Ghosh, Sudip
    Biswas, Monodeep
    Datta, Santanu
    Pattari, Sanjib
    Chatterjee, Shelly
    Bandyopadhyay, Arun
    Banerjee, Tanima
    JOURNAL OF HYPERTENSION, 2018, 36 : E255 - E255
  • [2] Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
    Ferreira, Joao Pedro
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 945 - 946
  • [3] Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
    Querejeta, R
    Varo, N
    López, B
    Larman, M
    Artiñano, E
    Etayo, JC
    Ubago, JLM
    Gutierrez-Stampa, M
    Emparanza, JI
    Gil, MJ
    Monreal, I
    Mindán, JP
    Diez, J
    CIRCULATION, 2000, 101 (14) : 1729 - 1735
  • [4] Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
    Ferreirra, Joao Pedro
    Cleland, John G.
    Girerd, Nicolas
    Rossignol, Patrick
    Pellicori, Pierpaolo
    Cosmi, Franco
    Mariottoni, Beatrice
    Gonzalez, Arantxa
    Diez, Javier
    Solomon, Scott D.
    Claggett, Brian
    Pfeffer, Marc A.
    Pitt, Bertram
    Petutschnigg, Johannes
    Pieske, Burkert
    Edelmann, Frank
    Zannad, Faiez
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 377 : 86 - 88
  • [5] Prognostic value of carboxy-terminal propeptide of type I procollagen in human colorectal carcinoma
    Eryavuz, Y
    Eroglu, A
    Demirci, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 223 - 223
  • [6] PROCOLLAGEN TYPE-I CARBOXY-TERMINAL PROPEPTIDE AS A MARKER OF OSTEOBLASTIC BONE METASTASES
    FRANCINI, G
    GONNELLI, S
    PETRIOLI, R
    BRUNI, S
    MARSILI, S
    AQUINO, A
    CAMPOREALE, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1993, 2 (02) : 125 - 129
  • [7] Role of adiponectin and its relationship to procollagen type I carboxy-terminal propeptide in essential hypertension
    Tsai, Wei-Chuan
    Lin, Chih-Chan
    Lee, Cheng-Han
    Li, Wei-Ting
    Chen, Ju-Yi
    Chen, Jyh-Hong
    CIRCULATION, 2006, 114 (18) : 773 - 774
  • [8] The Association Between Carboxy-Terminal Propeptide of Type I Procollagen and Aldosterone in Patients With Primary Aldosteronism
    Lin, Yen-Hung
    Wu, Vin-Cent
    Wu, Kwan-Dun
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (12) : 1321 - 1321
  • [9] Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations
    Stevenson, HP
    Leslie, H
    Sheridan, B
    ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 : 317 - 318
  • [10] Early Circulating Procollagen Type I Carboxy-Terminal Propeptide Levels After Acute Myocardial Infarction Correlate With Scar Size
    Driessen, Helen E.
    van Klarenbosch, Bas R.
    Kok, Bart J.
    Vos, Marc A.
    Cramer, Maarten J.
    Chamuleau, Steven A.
    van Veen, Toon A.
    Velthuis, Birgitta K.
    de Jong, Sanne
    CIRCULATION, 2018, 138